Natural Killer (NK) Cell Therapeutics Market Report

China Natural Killer (NK) Cell Therapeutics Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 20, 2022
  • PAGES：202
  • REPORT CODE：GMM1047216
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Natural Killer (NK) Cell Therapeutics market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Natural Killer (NK) Cell Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Natural Killer (NK) Cell Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • NantKwest Inc (USA)

    • Chipscreen Biosciences (China)

    • Sorrento Therapeutics Inc (USA)

    • Altor BioScience Corporation (USA)

    • Innate Pharma SA (France)

    • Bristol-Myers Squibb (USA)

    • Takeda Pharmaceutical (Japan)

    • NKT Therapeutics (USA)

    • Affimed NV (Netherlands)

    By Type:

    • Mogamulizumab

    • Lorvotuzumab Mertansine

    • Others

    By End-User:

    • Cancer

    • Cardiovascular Diseases

    • Others

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Natural Killer (NK) Cell Therapeutics Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Mogamulizumab from 2016 to 2027

    • 1.3.2 China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Lorvotuzumab Mertansine from 2016 to 2027

    • 1.3.3 China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Cancer from 2016 to 2027

    • 1.4.2 China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Cardiovascular Diseases from 2016 to 2027

    • 1.4.3 China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Natural Killer (NK) Cell Therapeutics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Natural Killer (NK) Cell Therapeutics by Major Types

    • 3.4.1 Market Size and Growth Rate of Mogamulizumab

    • 3.4.2 Market Size and Growth Rate of Lorvotuzumab Mertansine

    • 3.4.3 Market Size and Growth Rate of Others

    4 Segmentation of Natural Killer (NK) Cell Therapeutics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Natural Killer (NK) Cell Therapeutics by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Natural Killer (NK) Cell Therapeutics in Cancer

    • 4.4.2 Market Size and Growth Rate of Natural Killer (NK) Cell Therapeutics in Cardiovascular Diseases

    • 4.4.3 Market Size and Growth Rate of Natural Killer (NK) Cell Therapeutics in Others

    5 Market Analysis by Regions

    • 5.1 China Natural Killer (NK) Cell Therapeutics Production Analysis by Regions

    • 5.2 China Natural Killer (NK) Cell Therapeutics Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Natural Killer (NK) Cell Therapeutics Landscape Analysis

    • 6.1 North China Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Types

    • 6.2 North China Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major End-Users

    7 Central China Natural Killer (NK) Cell Therapeutics Landscape Analysis

    • 7.1 Central China Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Types

    • 7.2 Central China Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major End-Users

    8 South China Natural Killer (NK) Cell Therapeutics Landscape Analysis

    • 8.1 South China Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Types

    • 8.2 South China Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major End-Users

    9 East China Natural Killer (NK) Cell Therapeutics Landscape Analysis

    • 9.1 East China Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Types

    • 9.2 East China Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major End-Users

    10 Northeast China Natural Killer (NK) Cell Therapeutics Landscape Analysis

    • 10.1 Northeast China Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Types

    • 10.2 Northeast China Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major End-Users

    11 Southwest China Natural Killer (NK) Cell Therapeutics Landscape Analysis

    • 11.1 Southwest China Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Types

    • 11.2 Southwest China Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major End-Users

    12 Northwest China Natural Killer (NK) Cell Therapeutics Landscape Analysis

    • 12.1 Northwest China Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Types

    • 12.2 Northwest China Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 NantKwest Inc (USA)

      • 13.1.1 NantKwest Inc (USA) Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Chipscreen Biosciences (China)

      • 13.2.1 Chipscreen Biosciences (China) Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Sorrento Therapeutics Inc (USA)

      • 13.3.1 Sorrento Therapeutics Inc (USA) Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Altor BioScience Corporation (USA)

      • 13.4.1 Altor BioScience Corporation (USA) Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Innate Pharma SA (France)

      • 13.5.1 Innate Pharma SA (France) Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Bristol-Myers Squibb (USA)

      • 13.6.1 Bristol-Myers Squibb (USA) Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Takeda Pharmaceutical (Japan)

      • 13.7.1 Takeda Pharmaceutical (Japan) Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 NKT Therapeutics (USA)

      • 13.8.1 NKT Therapeutics (USA) Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Affimed NV (Netherlands)

      • 13.9.1 Affimed NV (Netherlands) Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Mogamulizumab from 2016 to 2027

    • Figure China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Lorvotuzumab Mertansine from 2016 to 2027

    • Figure China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Cancer from 2016 to 2027

    • Figure China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Cardiovascular Diseases from 2016 to 2027

    • Figure China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Natural Killer (NK) Cell Therapeutics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Natural Killer (NK) Cell Therapeutics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Natural Killer (NK) Cell Therapeutics by Different Types from 2016 to 2027

    • Table Consumption Share of Natural Killer (NK) Cell Therapeutics by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Mogamulizumab

    • Figure Market Size and Growth Rate of Lorvotuzumab Mertansine

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Natural Killer (NK) Cell Therapeutics by Different End-Users from 2016 to 2027

    • Table Consumption Share of Natural Killer (NK) Cell Therapeutics by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Cancer

    • Figure Market Size and Growth Rate of Cardiovascular Diseases

    • Figure Market Size and Growth Rate of Others

    • Table China Natural Killer (NK) Cell Therapeutics Production by Regions

    • Table China Natural Killer (NK) Cell Therapeutics Production Share by Regions

    • Figure China Natural Killer (NK) Cell Therapeutics Production Share by Regions in 2016

    • Figure China Natural Killer (NK) Cell Therapeutics Production Share by Regions in 2021

    • Figure China Natural Killer (NK) Cell Therapeutics Production Share by Regions in 2027

    • Table China Natural Killer (NK) Cell Therapeutics Consumption by Regions

    • Table China Natural Killer (NK) Cell Therapeutics Consumption Share by Regions

    • Figure China Natural Killer (NK) Cell Therapeutics Consumption Share by Regions in 2016

    • Figure China Natural Killer (NK) Cell Therapeutics Consumption Share by Regions in 2021

    • Figure China Natural Killer (NK) Cell Therapeutics Consumption Share by Regions in 2027

    • Table North China Natural Killer (NK) Cell Therapeutics Consumption by Types from 2016 to 2027

    • Table North China Natural Killer (NK) Cell Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure North China Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2016

    • Figure North China Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2021

    • Figure North China Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2027

    • Table North China Natural Killer (NK) Cell Therapeutics Consumption by End-Users from 2016 to 2027

    • Table North China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure North China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2016

    • Figure North China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2021

    • Figure North China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2027

    • Table Central China Natural Killer (NK) Cell Therapeutics Consumption by Types from 2016 to 2027

    • Table Central China Natural Killer (NK) Cell Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure Central China Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2016

    • Figure Central China Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2021

    • Figure Central China Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2027

    • Table Central China Natural Killer (NK) Cell Therapeutics Consumption by End-Users from 2016 to 2027

    • Table Central China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2016

    • Figure Central China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2021

    • Figure Central China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2027

    • Table South China Natural Killer (NK) Cell Therapeutics Consumption by Types from 2016 to 2027

    • Table South China Natural Killer (NK) Cell Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure South China Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2016

    • Figure South China Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2021

    • Figure South China Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2027

    • Table South China Natural Killer (NK) Cell Therapeutics Consumption by End-Users from 2016 to 2027

    • Table South China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure South China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2016

    • Figure South China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2021

    • Figure South China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2027

    • Table East China Natural Killer (NK) Cell Therapeutics Consumption by Types from 2016 to 2027

    • Table East China Natural Killer (NK) Cell Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure East China Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2016

    • Figure East China Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2021

    • Figure East China Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2027

    • Table East China Natural Killer (NK) Cell Therapeutics Consumption by End-Users from 2016 to 2027

    • Table East China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure East China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2016

    • Figure East China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2021

    • Figure East China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2027

    • Table Northeast China Natural Killer (NK) Cell Therapeutics Consumption by Types from 2016 to 2027

    • Table Northeast China Natural Killer (NK) Cell Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2016

    • Figure Northeast China Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2021

    • Figure Northeast China Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2027

    • Table Northeast China Natural Killer (NK) Cell Therapeutics Consumption by End-Users from 2016 to 2027

    • Table Northeast China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2016

    • Figure Northeast China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2021

    • Figure Northeast China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2027

    • Table Southwest China Natural Killer (NK) Cell Therapeutics Consumption by Types from 2016 to 2027

    • Table Southwest China Natural Killer (NK) Cell Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2016

    • Figure Southwest China Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2021

    • Figure Southwest China Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2027

    • Table Southwest China Natural Killer (NK) Cell Therapeutics Consumption by End-Users from 2016 to 2027

    • Table Southwest China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2016

    • Figure Southwest China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2021

    • Figure Southwest China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2027

    • Table Northwest China Natural Killer (NK) Cell Therapeutics Consumption by Types from 2016 to 2027

    • Table Northwest China Natural Killer (NK) Cell Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2016

    • Figure Northwest China Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2021

    • Figure Northwest China Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2027

    • Table Northwest China Natural Killer (NK) Cell Therapeutics Consumption by End-Users from 2016 to 2027

    • Table Northwest China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2016

    • Figure Northwest China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2021

    • Figure Northwest China Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of NantKwest Inc (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NantKwest Inc (USA)

    • Figure Sales and Growth Rate Analysis of NantKwest Inc (USA)

    • Figure Revenue and Market Share Analysis of NantKwest Inc (USA)

    • Table Product and Service Introduction of NantKwest Inc (USA)

    • Table Company Profile and Development Status of Chipscreen Biosciences (China)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chipscreen Biosciences (China)

    • Figure Sales and Growth Rate Analysis of Chipscreen Biosciences (China)

    • Figure Revenue and Market Share Analysis of Chipscreen Biosciences (China)

    • Table Product and Service Introduction of Chipscreen Biosciences (China)

    • Table Company Profile and Development Status of Sorrento Therapeutics Inc (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sorrento Therapeutics Inc (USA)

    • Figure Sales and Growth Rate Analysis of Sorrento Therapeutics Inc (USA)

    • Figure Revenue and Market Share Analysis of Sorrento Therapeutics Inc (USA)

    • Table Product and Service Introduction of Sorrento Therapeutics Inc (USA)

    • Table Company Profile and Development Status of Altor BioScience Corporation (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Altor BioScience Corporation (USA)

    • Figure Sales and Growth Rate Analysis of Altor BioScience Corporation (USA)

    • Figure Revenue and Market Share Analysis of Altor BioScience Corporation (USA)

    • Table Product and Service Introduction of Altor BioScience Corporation (USA)

    • Table Company Profile and Development Status of Innate Pharma SA (France)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Innate Pharma SA (France)

    • Figure Sales and Growth Rate Analysis of Innate Pharma SA (France)

    • Figure Revenue and Market Share Analysis of Innate Pharma SA (France)

    • Table Product and Service Introduction of Innate Pharma SA (France)

    • Table Company Profile and Development Status of Bristol-Myers Squibb (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb (USA)

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb (USA)

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb (USA)

    • Table Product and Service Introduction of Bristol-Myers Squibb (USA)

    • Table Company Profile and Development Status of Takeda Pharmaceutical (Japan)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical (Japan)

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical (Japan)

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical (Japan)

    • Table Product and Service Introduction of Takeda Pharmaceutical (Japan)

    • Table Company Profile and Development Status of NKT Therapeutics (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NKT Therapeutics (USA)

    • Figure Sales and Growth Rate Analysis of NKT Therapeutics (USA)

    • Figure Revenue and Market Share Analysis of NKT Therapeutics (USA)

    • Table Product and Service Introduction of NKT Therapeutics (USA)

    • Table Company Profile and Development Status of Affimed NV (Netherlands)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Affimed NV (Netherlands)

    • Figure Sales and Growth Rate Analysis of Affimed NV (Netherlands)

    • Figure Revenue and Market Share Analysis of Affimed NV (Netherlands)

    • Table Product and Service Introduction of Affimed NV (Netherlands)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US